Dechert, Shearman Rep On MedTech's $370M SPAC Merger
Chinese medical technology company Baird Medical and special-purpose acquisition company ExcelFin said Monday they would combine to take Baird public at a value of $370 million, in a deal guided by...To view the full article, register now.
Already a subscriber? Click here to view full article